Irving, Texas (PressExposure) April 21, 2009 -- Las Colinas Cancer Center deals in the treatment of prostate, breast cancer and additional cancer treatments through radiation therapy. It was founded by Gregory Echt, M.D., an experienced radiation oncologist.
Las Colinas Cancer Center has started treating cancer patients with Rapid Arc(TM) radiotherapy technology. Itâs a fast and precise form of treatment using advanced technology. The new Rapid Arc(TM) treatment is two to eight times faster than conventional forms of radiotherapy. The precision can make a significant difference in the patient's outcome. The cancer treatment with new Rapid Arc, target tumors exactly while sparing the surrounding healthy tissues. Because they're fast, Rapid Arc treatments are also easier on the patients.
The Las Colinas Cancer Center offerâs the following cancer services to its patients: â¢ Chemotherapy â¢ Radiation Therapy (IMRT and IGRT) â¢ Prostate Seed Implantation â¢ Mammosite Therapy â¢ PET/CT Scanner (adjacent facility) â¢ Hormonal Therapy â¢ Combination Therapy
Las Colinas Cancer Center offers cutting-edge cancer treatment to its breast cancer patients. The physicians of the Las Colinas Cancer Center are highly educated and experienced. The center uses finest technologies to deliver comfort to the patients in the north Texas area. They also offer compassion and understanding, knowing that emotional support is very important to the healing process for the breast cancer patients. For more information about the therapies, please visit: [http://www.lascolinascancercenter.com/contact_us.aspx].
About Las Colinas Cancer Center: The Las Colinas Cancer Center was founded by Gregory Echt, M.D., a radiation oncologist with more than 17 years of medical practice. Dr. Echt also founded North Texas Cancer Center of Wise in Decatur, Texas. In addition, he leads a radiation oncology practice at Medical City Hospital in Dallas and provides treatment for prostate cancer in private surgery centers across the north Texas region. Dr. Echt is also involved in clinical research for prostate cancer advancements.